<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Gilead Pharmasset LLC — New Patents | PatentBrief</title>
    <link>https://patentbrief.org/company/gilead-pharmasset-llc</link>
    <description>Plain-English explanations of patents assigned to Gilead Pharmasset LLC, newest first.</description>
    <language>en-us</language>
    <lastBuildDate>Mon, 15 Jun 2026 06:01:41 GMT</lastBuildDate>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://patentbrief.org/company/gilead-pharmasset-llc/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Chemical Compounds for Treating Hepatitis C Virus</title>
      <link>https://patentbrief.org/patent/us/8822430/epclusa-sofosbuvir-velpatasvir</link>
      <description>A patent describing specific chemical structures designed to stop the Hepatitis C virus from replicating in humans.</description>
      <pubDate>Tue, 02 Sep 2014 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://patentbrief.org/patent/us/8822430/epclusa-sofosbuvir-velpatasvir</guid>
    </item>
    <item>
      <title>Treating Hepatitis C with Combination Drug Therapy</title>
      <link>https://patentbrief.org/patent/us/8735372/sovaldi-sofosbuvir-composition</link>
      <description>A Gilead Sciences patent detailing a method to treat Hepatitis C by combining a specific chemical compound with an NS5a inhibitor.</description>
      <pubDate>Tue, 27 May 2014 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://patentbrief.org/patent/us/8735372/sovaldi-sofosbuvir-composition</guid>
    </item>
  </channel>
</rss>
